Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Niagen Bioscience Inc (NASDAQ: NAGE) closed the day trading at $5.42 down -3.56% from the previous closing price of $5.62. In other words, the price has decreased by -$3.56 from its previous closing price. On the day, 0.94 million shares were traded. NAGE stock price reached its highest trading level at $6.06 during the session, while it also had its lowest trading level at $5.37.
Ratios:
For a better understanding of NAGE, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.44 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 35.44. For the most recent quarter (mrq), Quick Ratio is recorded 3.06 and its Current Ratio is at 3.57. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.04.
On August 11, 2022, B. Riley Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $6 to $2.40.
On March 08, 2022, ROTH Capital started tracking the stock assigning a Buy rating and target price of $7.ROTH Capital initiated its Buy rating on March 08, 2022, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 07 ’25 when Lopez Carlos Luis bought 273 shares for $7.86 per share. The transaction valued at 2,146 led to the insider holds 2,251 shares of the business.
Jaksch Frank L Jr sold 37,161 shares of NAGE for $229,956 on Dec 13 ’24. The Director now owns 244,179 shares after completing the transaction at $6.19 per share. On Dec 13 ’24, another insider, Frank Jaksch Jr., who serves as the affiliate of the company, bought 37,161 shares for $6.19 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAGE now has a Market Capitalization of 421407168 and an Enterprise Value of 426816448. As of this moment, Niagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 51.47, and their Forward P/E ratio for the next fiscal year is 24.64. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.35. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.23 while its Price-to-Book (P/B) ratio in mrq is 9.09. Its current Enterprise Value per Revenue stands at 4.285 whereas that against EBITDA is 49.979.
Stock Price History:
The Beta on a monthly basis for NAGE is 1.98, which has changed by 0.38265312 over the last 52 weeks, in comparison to a change of -0.034466684 over the same period for the S&P500. Over the past 52 weeks, NAGE has reached a high of $9.18, while it has fallen to a 52-week low of $2.31. The 50-Day Moving Average of the stock is -16.45%, while the 200-Day Moving Average is calculated to be 10.36%.
Shares Statistics:
Over the past 3-months, NAGE traded about 846.72K shares per day on average, while over the past 10 days, NAGE traded about 740750 shares per day. A total of 77.33M shares are outstanding, with a floating share count of 49.23M. Insiders hold about 36.68% of the company’s shares, while institutions hold 29.21% stake in the company. Shares short for NAGE as of 1740700800 were 2105794 with a Short Ratio of 2.23, compared to 1738281600 on 2112969. Therefore, it implies a Short% of Shares Outstanding of 2105794 and a Short% of Float of 4.18.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
